Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-21-009021
Filing Date
2021-04-15
Accepted
2021-04-15 16:00:51
Documents
4
Period of Report
2021-05-14

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A atos20210408_def14a.htm DEF 14A 315946
2 logo.jpg GRAPHIC 11185
3 proxy.jpg GRAPHIC 245394
4 sig.jpg GRAPHIC 6165
  Complete submission text file 0001437749-21-009021.txt   673612
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Filer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35610 | Film No.: 21828477
SIC: 2834 Pharmaceutical Preparations